Source: Annual Congress 2004 - New insights on the role of different imaging methods in various clinical settings
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Dirksen, S. B. Shaker (Hellerup, Denmark). The prognostic value of CT-based lung density histograms in patients with severe alpha-1 antitrypsin deficiency. Eur Respir J 2004; 24: Suppl. 48, 1908

Member's Comments

No comment yet.

Related content which might interest you: Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease. Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 The effect of exacerbations on lung density in relation to patient characteristics in the RAPID-RCT trial of alpha-1 antitrypsin therapy Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases Year: 2021 Change in lung function and CT lung density in alpha1 antitrypsin deficiency patients under augmentation therapy Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency. Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Correlation between annual change in health status and CT-derived lung density in subjects with alpha-1-antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 385s Year: 2003 Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Ventilation inhomogeneity is correlated with biomarkers of parenchymal destruction in alpha1 antitrypsin deficiency Source: Eur Respir J 2007; 30: Suppl. 51, 620s Year: 2007 Alpha-1 antitrypsin COPD phenotypes are clinically more valid when defined by LLN rather than percent of predicted Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019 Initial values of alpha 1 antitrypsin and transferrin in patients with pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 660s Year: 2007 CT quantification of lung lesions as a prognostic factor for severe lung damage in COVID-19 patients Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Alpha-1 antitrypsin deficiency severity and the risk of COVID-19 Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Prevalence of mutations in the alpha 1 antitrypsin gene in patients with pulmonary emphysema Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Regional deposition of 99mTc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007